Transfusion Technology Assessment

Introduction

The joint Sanquin – Julius Center Transfusion Technology Assessment (TTA) unit, established in 2003, is an ongoing collaboration of Sanquin Blood Supply Foundation and the Health Technology Assessment department of the Julius Center for Health Sciences and Primary Care at Utrecht University. The unit was installed with the mission to provide scientific evidence to support informed decision making by Sanquin management and national and international policymakers based on statistical and mathematical modelling. Since its conception, TTA has performed various risk assessments and economic evaluations concerning blood safety. TTA has also established models for clinical blood use, blood recipient profiles and collected and analysed European data on blood use and supply. The TTA unit produces scientific publications, but also proprietary information to Sanquin Executive Board and Sanquin Plasma Products division. In the past years, in the course of the PROTON study, TTA has compiled an invaluable source of information on the blood transfusion chain (BTC) that is unique for the Netherlands and rare in the world. Since its establishment, the TTA group has been among the few groups worldwide to be involved in similar issues. TTA group members have been invited to share their expertise by organizations like WHO as the European Medicines Agency (EMA), the Council of Europe (EDQM) and the International Society for Blood Transfusion.

Medical needs

Funding

  • PPOC (internal funding in competition)
  • ZonMw (The Netherlands Organisation for Health Research and Development)
  • European Blood Alliance (EBA)
  • European Center for Disease Prevention and Control (ECDC)
  • WHO
  • Alliance of Blood Operators (ABO)

Our research